Risk factors for potential drug-drug interactions of statins in patients with acute coronary syndrome
Abstract The aim of our study was to assess risk factors for potential drug-drug interactions (pDDIs) of statins across different phases of treatment of acute coronary syndrome (ACS) patients: from the point of first medical contact to the coronary angiography (first phase), after coronary angiograp...
Saved in:
Main Authors: | Ana V. Pejčić (Author), Slobodan M. Janković (Author), Goran Davidović (Author) |
---|---|
Format: | Book |
Published: |
Universidade de São Paulo,
2022-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Drug-drug interactions in prescriptions for hospitalized elderly with Acute Coronary Syndrome
by: Tiago Aparecido Maschio de Lima, et al.
Published: (2017) -
Frequency and predictors of potential drug: Drug interactions in hospitalized patients with Parkinson's diseases
by: Aleksić Dejan Z., et al.
Published: (2021) -
Focus group and Delphi process: Stroke and potential drug-drug Interactions (pDDI) in the neurological Intensive Care Unit (NICU)
by: Aleksić Dejan Z., et al.
Published: (2021) -
Potential drug-drug interactions among patients with spontaneous intracerebral hemorrhage treated at the Neurological Intensive Care Unit: a single-center experience
by: Dejan Z. Aleksić, et al.
Published: (2022) -
Potential drug-drug interactions in drug therapy for older adults with chronic coronary syndrome at hospital discharge: A real-world study
by: Mei Zhao, et al.
Published: (2022)